Page last updated: 2024-09-05

gr 144053 and arginyl-glycyl-aspartyl-phenylalanine

gr 144053 has been researched along with arginyl-glycyl-aspartyl-phenylalanine in 1 studies

Compound Research Comparison

Studies
(gr 144053)
Trials
(gr 144053)
Recent Studies (post-2010)
(gr 144053)
Studies
(arginyl-glycyl-aspartyl-phenylalanine)
Trials
(arginyl-glycyl-aspartyl-phenylalanine)
Recent Studies (post-2010) (arginyl-glycyl-aspartyl-phenylalanine)
21123608

Protein Interaction Comparison

ProteinTaxonomygr 144053 (IC50)arginyl-glycyl-aspartyl-phenylalanine (IC50)
Integrin beta-3Homo sapiens (human)4.377
Integrin alpha-V Homo sapiens (human)4.1
Integrin alpha-IIbHomo sapiens (human)4.5155

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coller, BS; Lang, D; Scudder, LE1

Other Studies

1 other study(ies) available for gr 144053 and arginyl-glycyl-aspartyl-phenylalanine

ArticleYear
Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.
    Circulation, 1997, Feb-18, Volume: 95, Issue:4

    Topics: Abciximab; Analysis of Variance; Animals; Antibodies, Monoclonal; Hemagglutination; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Mice; Observer Variation; Oligopeptides; Piperazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Reference Values; Thrombasthenia

1997